Abstract Objective Cyanidin-3-glucoside (C3G) is the main active ingredient of anthocyanidin. This study aimed to evaluate the effects of C3G on body weight gain, visceral adiposity, lipid profiles and insulin resistance in high-fat diet-induced obese rats. Methods Thirty male Sprague-Dawley rats were randomly divided into a control group (n=8) and a high fat diet group (n=22), and were fed with standard diet or high fat diet. Five weeks later, 17 high-fat diet-induced obese rats were randomly given C3G [100 mg/(kg·d)] or normal saline via intragastric administration for 5 weeks. Five weeks later, body weight, visceral adiposity and food intake were measured. Blood samples were collected for detecting fasting glucose, serum insulin, lipid profiles and adiponectin. Insulin resistance index, atherosclerosis index and average feed efficiency ratio were calculated. Results C3G supplementation markedly decreased body weight, visceral adiposity, average feed efficiency ratio, triglyceride, total cholesterol, low density lipoprotein cholesterol, fasting glucose, serum insulin, insulin resistance index and atherosclerosis index in high-fat diet-induced obese rats. C3G supplementation normalized serum adiponectin and high density lipoprotein cholesterol levels in high-fat diet-induced obese rats. Conclusions Cyanidin-3-glucoside can reduce body weight gain, and attenuate obesity-associated dyslipidemia and insulin resistance in high-fat diet-fed rats via up-regulating serum adiponectin level.
Selassie M, Sinha AC. The epidemiology and aetiology of obesity: a global challenge[J]. Best Pract Res Clin Anaesthesiol, 2011, 25(1): 1-9.
[2]
Karpe F, Dickmann JR, Frayn KN. Fatty acids, obesity, and insulin resistance: time for a reevaluation[J]. Diabetes, 2011, 60(10): 2441-2449.
[3]
Achike FI, To NH, Wang H, et al. Obesity, metabolic syndrome, adipocytes and vascular function: A holistic viewpoint[J]. Clin Exp Pharmacol Physiol, 2011, 38(1): 1-10.
[4]
Li MF, Cheung BM. Rise and fall of anti-obesity drugs[J]. World J Diabetes, 2011, 2(2): 19-23.
[5]
Basu A, Du M, Leyva MJ, et al. Blueberries decrease cardiovascular risk factors in obese men and women with metabolic syndrome[J]. J Nutr, 2010, 140(9): 1582-1587.
[6]
Karlsen A, Paur I, Bohn SK, et al. Bilberry juice modulates plasma concentration of NF-kappaB related inflammatory markers in subjects at increased risk of CVD[J]. Eur J Nutr, 2010, 49(6): 345-355.
[7]
Prior RL, Wu X, Gu L, et al. Purified berry anthocyanins but not whole berries normalize lipid parameters in mice fed an obesogenic high fat diet[J]. Mol Nutr Food Res, 2009, 53(11): 1406-1418.
Galvano F, La Fauci L, Vitaglione P, et al. Bioavailability, antioxidant and biological properties of the natural free-radical scavengers cyanidin and related glycosides[J]. Ann Ist Super Sanita, 2007, 43(4): 382-393.
[11]
Takikawa M, Inoue S, Horio F, et al. Dietary anthocyanin-rich bilberry extract ameliorates hyperglycemia and insulin sensitivity via activation of AMP-activated protein kinase in diabetic mice[J]. J Nutr, 2010, 140(3): 527-533.
[12]
Prior RL, E Wilkes S, R Rogers T, et al. Purified blueberry anthocyanins and blueberry juice alter development of obesity in mice fed an obesogenic high-fat diet[J]. J Agric Food Chem, 2010, 58(7): 3970-3976.
[13]
Guo H, Liu G, Zhong R, et al. Cyanidin-3-O-β-glucoside regulates fatty acid metabolism via an AMP-activated protein kinase-dependent signaling pathway in human HepG2 cells[J]. Lipids Health Dis, 2012, 11: 10-12.
[14]
Guo H, Xia M, Zou T, et al. Cyanidin 3-glucoside attenuates obesity-associated insulin resistance and hepatic steatosis in high-fat diet-fed and db/db mice via the transcription factor FoxO1[J]. J Nutr Biochem, 2012, 23(4): 349-360.
[15]
Qin Y, Xia M, Ma J, et al. Anthocyanin supplementation improves serum LDL- and HDL-cholesterol concentrations associated with the inhibition of cholesteryl ester transfer protein in dyslipidemic subjects[J]. Am J Clin Nutr, 2009, 90(3): 485-492.
[16]
Seymour EM, Lewis SK, Urcuyo-Llanes DE, et al. Regular tart cherry intake alters abdominal adiposity, adipose gene transcription, and inflammation in obesi-ty-prone rats fed a high fat diet[J]. J Med Food, 2009, 12(5): 935-942.
[17]
He J, Giusti MM. Anthocyanins: natural colorants with health-promoting properties[J]. Annu Rev Food Sci Technol, 2010, 1: 163-187.
[18]
Fox CS, Massaro JM, Hoffmann U, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study[J]. Circulation, 2007, 116(1): 39-48.
[19]
Boullart AC, de Graaf J, Stalenhoef AF. Serum triglycerides and risk of cardiovascular disease[J]. Biochim Biophys Acta, 2012, 1821(5): 867-875.
[20]
Lecerf JM, de Lorgeril M. Dietary cholesterol: from physiology to cardiovascular risk[J]. Br J Nutr, 2011, 106(1): 6-14.
[21]
Towler MC, Hardie DG. AMP-activated protein kinase in metabolic control and insulin signaling[J]. Circ Res, 2007, 100(3): 328-341.
[22]
Brochu-Gaudreau K, Rehfeldt C, Blouin R, et al. Adiponectin action from head to toe[J]. Endocrine, 2010, 37(1): 11-32.
Mauray A, Felgines C, Morand C, et al. Bilberry anthocyanin-rich extract alters expression of genes related to atherosclerosis development in aorta of apo E-deficient mice[J]. Nutr Metab Cardiovasc Dis, 2012, 22(1): 72-80.
